Most Recent Articles about CRNX
Story Stocks: A Common Theme Continues as Rare Disease Therapeutics IPO Crinetics Pharma Sees Solid Demand (CRNX) http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=NS20180718090348StoryStocks Jul 18, 2018 - As many followers of the IPO market are well aware, pharmaceutical and biotech IPOs have recently en

Related Companies

Name Exchange Price Mkt Cap
NCNA NuCana plc NASDAQ $23.92 $760.92M
FIXX Homology Medicines, Inc. NASDAQ $20.05 $751.37M
AMAG AMAG Pharmaceuticals, Inc. NASDAQ $21.675 $747.2M
FLXN Flexion Therapeutics, Inc. NASDAQ $19.73 $746.1M
DVAX Dynavax Technologies Corporation NASDAQ $11.85 $741.99M
Sector: Health Care > Industry: Major Pharmaceuticals